Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Period	Debt/Equity
2015-12-31	0.41
2016-12-31	0.57
2017-12-31	0.79
2018-12-31	0.93
2019-12-31	1.18
2020-12-31	1.28
2021-12-31	18.16
2022-12-31	2.31
2023-12-31	1.45
2024-12-31	0.82

	A	B	C	D
1	Symbol	Price	Change	Volume
2	RMTI	$0.94	-1.04%	0.13M
3
4
5

Rockwell Medical Inc. (RMTI) Debt to Equity Ratio

Debt to Equity Ratio Data

Get Rockwell Medical Inc. Data in Excel

More RMTI Financial Data